Axa
VCYT icon

Axa’s Veracyte VCYT Stock Holding History

Axa’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-38,148
Closed -$1.13M – 1180
2025
Q1 		$1.13M Sell
38,148
-24,955
-40% -$951K ﹤0.01% 829
2024
Q4 		$2.5M Sell
63,103
-61,999
-50% -$2.35M 0.01% 708
2024
Q3 		$4.26M Buy
125,102
+109,092
+681% +$3.07M 0.01% 586
2024
Q2 		$347K Buy
+16,010
New +$337K ﹤0.01% 982
2022
Q2 		– Sell
-93,618
Closed -$2.58M – 1224
2022
Q1 		$2.58M Hold
93,618
– – 0.01% 789
2021
Q4 		$3.86M Buy
93,618
+934
+1% +$41.3K 0.01% 728
2021
Q3 		$4.3M Hold
92,684
– – 0.01% 719
2021
Q2 		$3.71M Hold
92,684
– – 0.01% 774
2021
Q1 		$4.98M Sell
92,684
-13,316
-13% -$767K 0.02% 715
2020
Q4 		$5.19M Sell
106,000
-149,000
-58% -$6.9M 0.02% 685
2020
Q3 		$8.29M Buy
255,000
+74,700
+41% +$2.37M 0.03% 513
2020
Q2 		$4.67M Buy
180,300
+1,915
+1% +$47.7K 0.02% 635
2020
Q1 		$4.34M Buy
178,385
+12,185
+7% +$307K 0.02% 556
2019
Q4 		$4.64M Sell
166,200
-52,450
-24% -$1.36M 0.02% 645
2019
Q3 		$5.25M Buy
+218,650
New +$5.82M 0.02% 638

Other funds holding VCYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Axa's VCYT Position: Q2 2025 in Review

Axa sold out of Veracyte (VCYT) in Q2 2025, closing a stake of 38,148 shares — an estimated $1.13M sold.

Axa first reported a position in VCYT in Q3 2019 and held it in 15 quarters. The position peaked at $8.29M in Q3 2020. 278 funds tracked by Wall St. Rank hold VCYT as of Q2 2025.

  • Axa reported no remaining Veracyte position as of Q2 2025 after selling out during the quarter.
  • Axa sold 38,148 Veracyte shares in Q2 2025, an estimated $1.13M.
  • Axa first reported a position in Veracyte in Q3 2019 and held it in 15 quarters.
  • Axa's Veracyte position peaked at $8.29M in Q3 2020.
  • 278 funds tracked by Wall St. Rank held Veracyte as of Q2 2025.

Based on Axa's 13F filing for Q2 2025, filed 14 Aug 2025.